Abstract
In a prospective study of 37 individuals in Spain who did not have AIDS or AIDS-related complex but were positive for antibody to HIV, 164 sequentially taken serum samples were tested for the presence of the p24 antigen of HIV. Six of the subjects were antigenemic at entry to the study and five of the remaining 31 subjects seroconverted for HIV antigen during follow-up. Six (55 %) of the 11 antigenemic patients but none of those without antigenemia developed AIDS. The interval from the time of first detection of HIV antigen to the diagnosis of AIDS varied greatly. The results confirm that individuals with HIV antigenemia run a significantly higher risk of developing AIDS.
Similar content being viewed by others
References
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., Broder, S. 3′ azido-3′-deoxythimidine (BM A509U): an antiviral agent that inhibits the infectivity and cytopathic effects of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proceedings of the National Academy of Sciences of the USA 1985, 82: 7096–7100.
Anonymous: Zivovudine. Lancet 1987, i: 957–958.
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., Phil, D., King, D. andthe AZT Collaborative Working Group The efficacy of azidothimidine in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. New England Journal of Medicine 1987, 317: 185–191.
Lange, J. M. A., Richman, D. D., Grieco, M. H., de Wolf, F., van der Berg, H., Coutinho, R. A., Danner, S. A., van der Noordaa, J., Goudsmit, J. Persistent HIV antigenemia and decline of HIV core antibodies associated with transition to AIDS. British Medical Journal 1986, 293: 1459–1462.
Pedersen, C., Nielsen, C. M., Vestergaard, B. F., Krogsgaard, K., Nielsen, J. O. Temporal relation of antigenemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. British Medical Journal 1987, 295: 567–569.
De Wolf, F., Goudsmit, J., Paul, D., Lange, J. M. A., Hooijkaas, C., Schellekens, P., Coutinho, R. A., van der Noordaa, J. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenemia. British Medical Journal 1987, 295: 569–572.
Allain, J. P., Laurian, Y. L., Paul, D., Verroust, F., Leuther, M., Gazengel, C., Senn, D., Larrieu, M. J., Bosser, C. Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. New England Journal of Medicine 1987, 317: 1114–1121.
Moss, A. R., Bacchetti, P., Osmond, D., Krampf, W., Chaisson, R. E., Stites, D., Wilber, J., Allan, J. P., Carlson, J. Seropositivity for HIV and the development of AIDS or AIDS related condition. Three year follow-up of the San Francisco General Hospital cohort. British Medical Journal 1988, 296: 745–750.
Mayer, K. H., Falk, L. A., Paul, D. A., Dawson, G. J., Stoddard, A. M., Mccusker, J., Saltzman, S. P., Moon, M. W., Ferriani, R., Groopman, J. E. Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men. American Journal of Medicine 1987, 83: 208–212.
Frösner, G. G., Erfle, V., Meller, W., Helhmann, R. Diagnostic significance of quantitative determination of HIV antibody specific for envelope and core proteins. Lancet 1987, i: 159–160.
Weber, J. N., Clapham, P. R., Weiss, R. A., Parker, P. R., Roberts, C., Duncan, J., Weller, I., Carne, C., Tedder, R. S., Pinching, A. J., Cheingsong-Popov, R. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-GAG antibody with prognosis. Lancet 1987, i: 119–122.
Simmonds, P., Lainson, F. A. L., Cuthbert, R., Steel, C. M., Peutherer, J. F., Ludlam, C. A. HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort. British Medical Journal 1988, 296: 593–598.
Centers for Disease Control Classification system for human t-lymphotrophic virus type III/lymphadenopathy associated virus infections. Morbidity and Mortality Weekly Report 1986, 35: 334–339.
Jackson, G. G., Paul, D., Falk, L. A., Rubenis, M., Despotes, J. C., Mack, D., Knigge, M., Emerson, E. E. Human immunodeficiency virus antigenemia (p24) in the acquired immunodeficiency syndrome and the effect of treatment with zidovudine. Annals of Internal Medicine 1988, 108: 175–180.
Leal, M., Rey, C., Pineda, J. A., Garcia de Pesquera, F., Navarro, M. D., Soto, B., Sánchez-Quijano, A., Lissen, E. Expresión sérica del (de los) antígeno(s) del virus de la inmunodeficiencia humana (Ag-VIH) en personas de riesgo. Evidencia de desaparición del Ag-VIH en el curso evolutivo de pacientes con síndrome de inmunodeficiencia adquirida. Medicina Clínica 1987, 89: 634–637.
Cao, Y., Valentine, F., Hojvat, S., Allain, J. P., Rubinstein, P., Mirabile, M., Czelusniak, S., Leuther, M., Baker, L., Friedman-Kien, A. E. Detection of HIV antigen and specific antibodies to core and envelope protein in sera of patients with infection. Blood 1987, 70: 575–578.
Goudsmit, J., Lange, J. M. A., Paul, D., Dawson, G. J. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex and subclinical human immunodeficiency virus infection. Journal of Infectious Diseases 1987, 155: 558–560.
Allain, J. P., Laurian, Y., Paul, D., Sennd, P. Serological markers in early stages of human immuno-deficiency virus infection in haemophiliacs. Lancet 1986, ii: 1233–1236.
Kessler, H. A., Blaauw, B., Spear, J., Paul, D., Falk, L. A., Landay, A. Diagnosis of human immunodeficiency virus infection in seronegative homosexual presenting with an acute viral syndrome. Journal of the American Medical Association 1987, 258: 1196–1218.
Calabrese, L. H., Proffitt, M. R., Levin, K. H., Yen-Lieberman, B., Starkey, C. Acute infection with the human immunodeficiency virus associated with acute brachial neuritis and exanthema rash. Annals of Internal Medicine 1987, 107: 849–851.
Falk, L. A., Paul, D., Landay, A., Kessler, H. HIV isolation plasma of HIV-infected persons. New England Journal of Medicine 1987, 316: 1547–1548.
Lelie, P. N., Reesink, H. W., Huisman, H. Evaluation of three second-generation and three confirmatory assays for antibodies to human immunodeficiency virus. Vox Sanguinis 1988, 54: 84–91.
De Wolf, F., Lange, J. M. A., Goudsmit, J., Cload, P., de Gans, J., Schellekens, P. T. A., Coutinho, R. A., Fiddian, A. P., van der Noordaa, J. Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. Lancet 1988, i: 373–376.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leal, M., Pineda, J.A., Calderón, E.J. et al. Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 8, 244–248 (1989). https://doi.org/10.1007/BF01965269
Issue Date:
DOI: https://doi.org/10.1007/BF01965269